Summary
In the United Kingdom, acute bleeding from peptic ulcer is estimated to account for 25 admissions to hospital per 100 000 population annually. Overall mortality has been reported at around 10%.
Accurate initial assessment for the identification of high risk groups, prompt resuscitation, close monitoring and timely intervention for rebleeding improves survival. In patients not responding to initial resuscitation and those who rebleed, emergency endoscopy identifies the source of bleeding in the majority and is essential to enable endoscopic therapy. Injection of a vasoconstrictor and/or sclerosant into a visible or bleeding vessel, or thermal coagulation, reduces the incidence of rebleeding and probably decreases mortality. In general terms, ‘early’ surgical intervention is indicated for those aged over 60 years in whom bleeding recurs or continues despite endoscopic measures. The low mortality (<5%) reported from specialist units and units adhering to strict protocols of management should become the norm. The use of antacids, histamine H2-receptor antagonists or omeprazole does not influence mortality or the incidence of early rebleeding in patients with acute haemorrhage from peptic ulcer. Although not used routinely, tranexamic acid has been shown to have significant benefit.
Similar content being viewed by others
References
Allan R, Dykes PA. A study of the factors influencing mortality rates from gastrointestinal haemorrhage. Quarterly Journal of Medicine 45: 533–550, 1976.
Barer D, Ogilvie A, Henry D, Dronfield M, Coggon D, et al. Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. New England Journal of Medicine 308: 1571–1575, 1983.
Birnie GC, Fenn GC, Shield MJ, Robinson GC. Double blind comparative study of misoprostol with placebo in acute upper gastrointestinal bleeding. Gut 32: A1246, 1991.
Bornman PC, Theodorou NA, Shuttleworth RD, Essel HP, Markes IN. Importance of hypovolaemic shock and endoscopic signs in predicting recurrent haemorrhage in peptic ulceration: a prospective evaluation. British Medical Journal 291: 245–247, 1985.
Bown S. Bleeding peptic ulcers, veni, vidi, vici per via naturalis. British Medical Journal 302: 1417–1418, 1991.
Chester JF, Hurley PR. Gastric necrosis: a complication of endoscopie sclerosis for bleeding peptic ulcer. Endoscopy 22: 287–8, 1990.
Chung SCS, Leung JWC, Steele RJC, Crofts TJ, Li AKC. Endoscopie injection of adrenaline for actively bleeding ulcers: a randomised trial. British Medical Journal 296: 1631–1633, 1988.
Chung SCS, Leung JWC, Sung JY, Lo KK, Li AKC. Injection or heat probe for bleeding ulcer. Gastroenterology 100: 33–37, 1991.
Choudari CP, Rajgopal C, Palmer KR. A comparison of endoscopie injection therapy versus the heater probe in major peptic ulcer haemorrhage. Gut 33: 1159–1161, 1992.
Clements D, Asian S, Foster D, Stamatakis J, Wilkins WE, et al. Acute upper gastrointestinal haemorrhage in a district general hospital: audit of an agreed management policy. Journal of the Royal College of Physicians of London 25: 27–30, 1991.
Collins R, Langman MJS. Treatment with histamine H2 antagonists in acute upper gastrointestinal haemorrhage. New England Journal of Medicine 331: 660–666, 1985.
Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopie therapy for acute nonvariceal upper gastrointestinal haemorrhage: a meta-analysis. Gastroenterology 102: 139–148, 1992.
Daneshmend TK, Hawkey CJ, Langman MJS, Logan RFA, Long RG, et al. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double-blind controlled trial. British Medical Journal 304: 143–147, 1992.
Dronfield MW, Atkinson M, Langman MJS. Effect of different operation policies on mortality from bleeding peptic ulcer. Lancet 1: 1126–1128, 1979.
Dronfield MW. Special units for acute upper gastrointestinal bleeding. British Medical Journal 294: 1308–1309, 1987.
Duggan JM. Haematemesis and melaena should be managed in special units. Medical Journal of Australia 144: 247–249, 1986.
Dykes PW. The rates of distribution and catabolism of albumin in normal subjects and in patients with cirrhosis of the liver. Clinical Science 34: 161–183, 1968.
Freitas D, Donato A, Monteiro JG. Controlled trial of liquid monopolar electrocoagulation in bleeding peptic ulcers. American Journal of Gastroenterology 80: 853–857, 1985.
Fullarton G, Birnie GC, Macdonald A, Murray WR. Controlled trial of heater probe treatment in bleeding peptic ulcers. British Journal of Surgery 76: 541–544, 1989.
Fullarton GM, MacDonald AM, Mann SG, McColl KEL. Controlled study of the effects of intravenous famotidine on intragastric pH in bleeding peptic ulcers. Alimentary Pharmacology and Therapeutics 5: 7–84, 1991.
Gordon-Taylor D. The problem of bleeding peptic ulcer. British Journal of Surgery 25: 403–425, 1937.
Green FW, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal haemorrhage. Gastroenterology 74: 38–43, 1978.
Griffiths WJ, Neumann DA, Welsh JD. The visible vessel as an indicator of uncontrolled or recurrent gastrointestinal haemorrhage. New England Journal of Medicine 300: 1411–1413, 1979.
Harvey RF, Langman MJS. The late results of medical and surgical treatment for bleeding duodenal ulcer. Quarterly Journal of Medicine 39: 539–547, 1970.
Henry DA, O’Connell DL. Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. British Medical Journal 298: 1142–1146, 1989.
Hunt PS, Hansky J, Korman MG. Mortality in patients with haematemesis and melaena: a prospective study. British Medical Journal (i): 1238–1240, 1979.
Hunt PS. Bleeding gastroduodenal ulcers: selection of patients for surgery. World Journal of Surgery 11: 289–294, 1987.
Jensen DM, You S, Jensen ME, Kovacs TOG, Machicado GA, et al. Randomised controlled study of ranitidine maintenance for patients with a recent severe duodenal ulcer haemorrhage. Gastroenterology 98: A65, 1990.
Krejs GJ, Little KH, Westergaard H, Hamilton JK, Spady DK, et al. Laser photocoagulation for the treatment of acute peptic ulcer bleeding. A randomised clinical trial. New England Journal of Medicine 316: 1618–1621, 1987.
Laine LA. Multipolar electrocoagulation of active upper gastrointestinal tract haemorrhage. A prospective controlled trial. New England Journal of Medicine 316: 1613–1617, 1987.
Laine LA. Multipolar electrocoagulation in the treatment of ulcers with nonbleeding visible vessels: a prospective controlled trial. Annals of Internal Medicine 110: 510–514, 1989.
Laine L, Cohen H, Brodhead J, Cantor D, Garcia F, et al. Prospective evaluation of early versus delayed refeeding and prognostic value of endoscopy in patients with upper gastrointestinal hemorrhage. Gastroenterology 102: 314–316, 1992.
Lennard-Jones JE. Report of a joint working group: Guidelines for good practice in and audit of the management of upper gastrointestinal haemorrhage. Journal of the Royal College of Physicians of London 26: 281–289, 1992.
Levy J, Khakoo S, Barton R, Vicary R. Fatal injection sclerotherapy of a bleeding ulcer. Lancet 337: 504, 1991.
Lin HJ, Lee FY, Kang WM, Tsai YT, Lee SD, et al. Heat probe thermocoagulation and pure alcohol injection in massive peptic ulcer haemorrhage: a prospective, randomised controlled trial. Gut 31: 753–757, 1990.
Loizou LA, Bown SG. Endoscopic treatment for bleeding peptic ulcers: randomised comparison of adrenaline injection and adrenaline injection + Nd: YAG laser photocoagulation. Gut 32: 110–113, 1991.
Loperfido S, Patelli G, La Torre L. Extensive necrosis of gastric mucosa following injection therapy of bleeding peptic ulcer. Endoscopy 22: 285–6, 1990.
Madden MV, Griffith GH. Management of upper gastrointestinal bleeding in a district general hospital. Journal of the Royal College of Physicians of London 20: 212–215, 1986.
Magnussen I, Ihre T, Johansson C, Seligson U, Torngren S, et al. Randomised double-blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage. Gut 26: 221–226, 1985.
Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1: 1437–1442, 1988.
Mathewson K, Swain CP, Bland M, Kirkham JS, Bown SG, et al. Randomised comparison of Nd-YAG laser, heater probe and no endoscopic therapy for bleeding peptic ulcer. Gastroenterology 98: 1239–1244, 1990.
Mcleod IA, Mills PR. Factors identifying the probability of further haemorrhage after acute upper gastrointestinal haemorrhage. British Journal of Surgery 69: 256–258, 1982.
Merki HS, Witzel L, Kaufman D, Kempf M, Neumann J, et al. Continuous infusions of famotidine maintain high intragastric pH in duodenal ulcer. Gut 29: 453–457, 1988.
Moreto M, Zaballa M, Ibanez S, Setiem F, Figa M. Efficacy of monopolar electrocoagulation in the treatment of bleeding gastric ulcer: a controlled trial. Endoscopy 19: 54–56, 1987.
Morris DL, Hawker PC, Brearley S, Simms M, Dykes PW, et al. Optimal timing of operation for bleeding peptic ulcer: prospective randomised trial. British Medical Journal 288: 1277–1280, 1984.
Murray WR, Cooper G, Laferla G, Rogers P, Archibald M. Maintenance ranitidine treatment after haemorrhage from a duodenal ulcer. Scandinavian Journal of Gastroenterology 23: 183–187, 1988.
O’Brien JD, Day SJ, Burnham WR. Controlled trial of small bipolar probe in bleeding peptic ulcers. Lancet 1: 464–467, 1986.
Oxner RBG, Simmonds NJ, Gertner DJ, Nightingale JMD, Burnham WR. Controlled trial of endoscopie injection treatment for bleeding from peptic ulcers with visible vessels. Lancet 339: 966–968, 1992.
Panes J, Viver J, Forne M, Garcia-Olivares E, Marco C, et al. Controlled trial of endoscopie sclerosis in bleeding peptic ulcers. Lancet 2: 1292–1294, 1987.
Pascu O, Draghici A, Acalovchi I. The effect of endoscopie hemostasis with alcohol on the mortality rate of nonvariceal upper gastrointestinal hemorrhage. A randomised prospective study. Endoscopy 21: 53–55, 1989.
Rajgopal C, Palmer KR. Endoscopie injection sclerosis: effective treatment for bleeding peptic ulcer. Gut 32: 727–729, 1991.
Rauws EAJ, Tytgat GNJ. Eradication of Helicobacter pylori cures duodenal ulcer. Lancet 1: 1233–1235, 1990.
Reynolds JR, Walt RP, Clark AG, Hardcastle JD, Langman MJS. Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetidine and ranitidine. Alimentary Pharmacology and Therapeutics 1: 23–30, 1987.
Robinson GC, Shield MJ, Fenn GC. Misoprostol versus placebo in prevention of recurrence of acute upper gastrointestinal haemorrhage: a randomised double blind study. Gut 32: A572, 1991.
Rutgeerts P, Vantrappen G, Broeckaert L. Controlled trial of VAG lasertreatment of upper digestive haemorrhage. Gastroenterology 83: 410–416, 1982.
Rutgeerts P, Vantrappen G, Broeckaert L, Coremans G, Janssens Hiele M. Comparison of endoscopie polidocanol injection and Yag Laser therapy for bleeding peptic ulcers. Lancet 1: 1164–1166, 1989.
Rutgeerts P, Gevers AM, Hiele M, Broeckaert L, Vantrappen G. Endoscopie injection therapy to prevent rebleeding from peptic ulcers with a protruding vessel: a controlled comparative trial. Gut 34: 348–350, 1993.
Sanderson JD, Taylor RFH, Pugh S, Vicary FR. Specialised gastrointestinal units for the management of upper gastrointestinal haemorrhage. Postgraduate Medical Journal 66: 654–656, 1990.
Schiller KFR, Truelove SC, Williams D, Gwyn. Haematemesis and melaena with special reference to factors influencing outcome. British Medical Journal 2: 7–14, 1970.
Smart HL, Langman MJS. Late outcome of bleeding gastric ulcers. Gut 27: 926–928, 1986.
Soderland C. Vasopressin and glypressin in upper gastrointestinal bleeding. Scandinavian Journal of Gastroenterology 22 (suppl. 137): 50–55, 1987.
Somerville KW, Henry DA, Davies JG, Hine KR, Hawkey CJ, et al. SGmatostatin in the treatment of haematemesis and melaena. Lancet 1: 130–132, 1985.
Storey DW, Bown SG, Swain CP, Salmon PR, Kirkham JS, et al. Endoscopie prediction of recurrent bleeding in peptic ulcers. New England Journal of Medicine 305: 915–916, 1981.
Swain CP, Bown SG, Storey DW, Kirkham JS, Salmon PR, et al. Controlled trial of Argon Laser photocoagulation in bleeding peptic ulcer. Lancet 2: 1313–1316, 1981.
Swain CP, Bown SG, Salmon PR, Kirkham JS, Northfield TC. Controlled trial of Nd-YAG laser photocoagulation for bleeding peptic ulcer. Lancet 1: 113–116, 1986.
Vallon AG, Cotton PB, Laurence BH, Armengol-Miro JR, Saloro-Uses JC. Randomised trial of endoscopic Argon Laser photocoagulation in bleeding peptic ulcers. Gut 22: 228–233, 1981.
Walt RP, Reynolds JR, Langman MJS, Smart HL, Kitchingman G, et al. Intravenous omeprazole rapidly raises intragastric pH. Gut 26: 902–906, 1985.
Walt RP, Cottrell J, Mann SG, Freemantle NP, Langman MJS. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet 340: 1058–62, 1992.
Wara P. Endoscopie prediction of major rebleeding — a prospective study of stigmata of hemorrhage in bleeding peptic ulcer. Gastroenterology 88: 1209–1214, 1985.
Wheatley KE, Snyman JH, Brearley S, Keighley MRB, Dykes PW. Mortality in patients with bleeding peptic ulcer when those aged 60 or over are operated on early. British Medical Journal 301: 272, 1990.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Panos, M.Z., Walt, R.P. Current Management of Bleeding Peptic Ulcer. Drugs 46, 269–280 (1993). https://doi.org/10.2165/00003495-199346020-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199346020-00005